Advertisement
Home 2017

Archives

For women with diabetes

Caffeine Tied to Lower Mortality in Women With Diabetes

0
Women who consumed caffeine from coffee had reduced risk of all-cause, cardiovascular deaths
Sotagliflozin is associated with improved glycemic control in patients with type 1 diabetes receiving insulin

Sotagliflozin Linked to Improved Glycemic Control in T1DM

0
Primary end point achieved by more patients with type 1 diabetes receiving any insulin therapy
For patients with type 2 diabetes

Exenatide Doesn’t Up Cardiovascular Risk in T2DM

0
Exenatide found to be non-inferior to placebo with respect to safety for patients with type 2 diabetes
A clinical consensus statement on balloon dilation of the sinuses has been approved by the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Board of Directors and presented at the annual meeting of the American Academy of Otolaryngology-Head and Neck Surgery

AAO-HNSF: New Consensus on Balloon Dilation of Sinuses

0
Clinical consensus statement for adults 18 years or older with chronic or recurrent rhinosinusitis
Significant increases are seen in blood pressure

BP, Heart Rate, Arterial Stiffness Up With E-Cigarettes

0
Significant increases seen in first 30 minutes after smoking electronic-cigarette containing nicotine
Adjuvant therapy with nivolumab is associated with longer recurrence-free survival than therapy with ipilimumab among patients undergoing resection of stage IIIB

Adjuvant Nivolumab Tops Ipilimumab in Melanoma

0
Longer recurrence-free survival for stage IIIB, IIIC, IV melanoma
Patients with chronic obstructive pulmonary disease with an eosinophilic phenotype may benefit from mepolizumab

Mepolizumab Beneficial in COPD With Eosinophilic Phenotype

0
Lower annual rate of moderate, severe exacerbations for patients receiving 100 mg mepolizumab
For patients with resected stage III melanoma with BRAF V600E or V600K mutations

Dabrafenib, Trametinib Beneficial in Resected Melanoma

0
Rate of relapse-free survival up for resected stage III melanoma with BRAF V600E, V600K mutations
For patients with moderate or severe obstructive sleep apnea

AAO-HNS: Improvement in OSA With Cranial Nerve Stimulation

0
Decrease in apnea-hypopnea index, and improvement in oxygen saturation, sleepiness, quality of life
Romosozumab treatment followed by alendronate is linked to reduced risk of fractures versus alendronate alone for postmenopausal women with osteoporosis

ASBMR: Romosozumab Reduces Fracture Rate in Osteoporosis

0
Reduced risk of new vertebral fractures, nonvertebral fractures for romosozumab and alendronate